Q2-Header_1280x350_6_mob

Orphan Drug and Vaccine Development for Rare Diseases

Clinical trial vaccine lab solutions for orphan drug and vaccine development

Drug developers for rare diseases require a partner that understands the unique, complex needs of orphan drug development. Q2 Solutions’ industry-leading scientists partner with you to optimize your study design and accelerate regulatory approval.

With global vaccine laboratory solutions, we offer assay development services, immunogenicity testing, genomic solutions, efficacy monitoring, project management and data management.

Our Vaccines Center of Excellence is located in San Juan Capistrano, CA.

Learn more

Related Thought Leaders Insights

White Paper

Through a CRO's Perspective: Innovative, Agile Solutions In Vaccine Efficacy Testing

The outbreak of the SARS-CoV-2 virus caused a sudden shift in focus for the pharmaceutical industry. After the genetic sequence of the virus was released in early 2020, manufacturers across the globe...

Presentation

In vivo model design and assay selection to aid in progression from preclinical to clinical

Vaccine development is a complex path with multiple checkpoints and steps. In this presentation, we discuss the critical factors that must be assessed in the preclinical stage including: animal...

Presentation

Considerations to select optimal functional assay for comprehensive vaccine efficacy data

In this presentation, we consider the available options to those looking to develop the best available assay to study vaccine efficacy. By focusing on the two types of immunity, researchers can...